StonvexLoading…
StonvexStonvexStonvexCore line items from DKL's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $1.01B | $940.64M | $1.02B | $1.04B |
Operating Income | $181.84M | $202.83M | $238.95M | $209.68M |
Net Income | $176.46M | $142.69M | $126.24M | $159.05M |
EPS (Diluted) | Not available | Not available | Not available | Not available |
Total Assets | $2.78B | $2.04B | $1.64B | $1.68B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $10.89M | $5.38M | $3.75M | $7.97M |
Free Cash Flow OCF − CapEx | $-30.64M | $77.30M | $129.22M | $51.07M |
Shares Outstanding | Not available | Not available | Not available | Not available |